Data:
{
"symbol": "IDYA",
"price": 40.17,
"marketCap": 3819488127,
"beta": -0.091,
"lastDividend": 0,
"range": "23.23-42.68",
"change": 0.22,
"changePercentage": 0.55069,
"volume": 765283,
"averageVolume": 1004398,
"companyName": "IDEAYA Biosciences, Inc.",
"currency": "USD",
"cik": "0001676725",
"isin": "US45166A1025",
"cusip": "45166A102",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.ideayabio.com",
"description": "IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a (MAT2A) blocking agent, is currently in early-stage (Phase I) trials for solid tumors exhibiting methylthioadenosine phosphorylase (MTAP) deletions. Its second primary candidate, IDE196, a protein kinase C (PKC) inhibitor, is progressing through Phase I/II studies, targeting genetically defined cancers characterized by GNAQ or GNA11 gene mutations. Beyond its clinical pipeline, IDEAYA's earlier-stage portfolio includes several synthetic lethality programs. These encompass a PARG inhibitor designed to address tumors with specific genetic or molecular biomarkers, Pol Theta inhibitors aimed at cancers presenting with BRCA or other homologous recombination deficiency (HRD) mutations, and WRN inhibitors for tumors demonstrating high microsatellite instability (MSI-H). The company also engages in significant collaborations. It has a joint research effort with Cancer Research UK and the University of Manchester, focusing on small molecule inhibitors of Poly (ADP-ribose) glycohydrolase. Furthermore, IDEAYA maintains a partnership with Pfizer Inc. for the clinical development and supply in Phase I/II trials across metastatic uveal melanoma, skin melanoma, and other solid tumors, alongside a strategic alliance with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was established in 2015 and operates from its headquarters in South San Francisco, California.",
"ceo": "Yujiro S. Hata",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "145",
"phone": "650 443 6209",
"address": "7000 Shoreline Court",
"city": "South San Francisco",
"state": "CA",
"zip": "94080",
"image": "https://images.financialmodelingprep.com/symbol/IDYA.png",
"ipoDate": "2019-05-23",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "IDYA",
"name": "IDEAYA Biosciences, Inc.",
"price": 39.89,
"changePercentage": -0.69704,
"change": -0.28,
"volume": 104274,
"dayLow": 39.745,
"dayHigh": 40.41,
"yearHigh": 42.68,
"yearLow": 23.23,
"marketCap": 3792864859,
"priceAvg50": 37.4336,
"priceAvg200": 33.6615,
"exchange": "NASDAQ",
"open": 40.41,
"previousClose": 40.17,
"timestamp": 1788449175,
"chart_vwap_daily": [
{
"t": "2026-07-24",
"v": 35.8884,
"c": 35.4
},
{
"t": "2026-07-27",
"v": 36.6402,
"c": 36.77
},
{
"t": "2026-07-28",
"v": 36.0487,
"c": 36.16
},
{
"t": "2026-07-29",
"v": 35.8468,
"c": 35.59
},
{
"t": "2026-07-30",
"v": 35.9802,
"c": 36.4
},
{
"t": "2026-07-31",
"v": 35.5866,
"c": 35.5
},
{
"t": "2026-08-03",
"v": 35.3272,
"c": 35.4
},
{
"t": "2026-08-04",
"v": 36.1589,
"c": 36.11
},
{
"t": "2026-08-05",
"v": 36.2316,
"c": 36.04
},
{
"t": "2026-08-06",
"v": 36.2731,
"c": 36.24
},
{
"t": "2026-08-07",
"v": 36.7815,
"c": 37.02
},
{
"t": "2026-08-10",
"v": 36.8596,
"c": 36.74
},
{
"t": "2026-08-11",
"v": 36.7955,
"c": 36.84
},
{
"t": "2026-08-12",
"v": 36.8851,
"c": 36.96
},
{
"t": "2026-08-13",
"v": 36.9325,
"c": 36.68
},
{
"t": "2026-08-14",
"v": 36.2517,
"c": 36.3
},
{
"t": "2026-08-17",
"v": 36.5671,
"c": 36.54
},
{
"t": "2026-08-18",
"v": 37.4857,
"c": 37.93
},
{
"t": "2026-08-19",
"v": 38.8528,
"c": 38.87
},
{
"t": "2026-08-20",
"v": 38.7965,
"c": 39.11
},
{
"t": "2026-08-21",
"v": 39.9147,
"c": 39.67
},
{
"t": "2026-08-24",
"v": 40.1186,
"c": 40.04
},
{
"t": "2026-08-25",
"v": 42.0387,
"c": 42.48
},
{
"t": "2026-08-26",
"v": 41.6737,
"c": 41.58
},
{
"t": "2026-08-27",
"v": 41.7299,
"c": 41.77
},
{
"t": "2026-08-28",
"v": 40.5609,
"c": 40.11
},
{
"t": "2026-08-31",
"v": 40.0225,
"c": 40.1
},
{
"t": "2026-09-01",
"v": 39.6512,
"c": 39.95
},
{
"t": "2026-09-02",
"v": 40.1107,
"c": 40.17
},
{
"t": "2026-09-03",
"v": 40.0276,
"c": 39.95
}
],
"vwap_summary": {
"days": 30,
"days_above": 16,
"days_below": 14,
"pct_days_above": 53,
"position": "below",
"gap_pct": -0.19,
"streak_days": 1
}
}
Data:
{
"volume": 104274,
"avgVolume": 1004398,
"short_ratio": [
{
"symbol": "IDYA",
"file_date": "2026-09-02",
"date": "20260902",
"short_volume": 153955,
"short_exempt_volume": 0,
"total_volume": 305509,
"short_volume_ratio": 0.5039,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 40.09,
"vah": 42.64,
"val": 37.77,
"profile": [
{
"price": 35.9,
"volume": 24872
},
{
"price": 36.01,
"volume": 46002
},
{
"price": 36.13,
"volume": 79608
},
{
"price": 36.24,
"volume": 72380
},
{
"price": 36.35,
"volume": 176000
},
{
"price": 36.47,
"volume": 164719
},
{
"price": 36.58,
"volume": 287127
},
{
"price": 36.69,
"volume": 436430
},
{
"price": 36.81,
"volume": 450082
},
{
"price": 36.92,
"volume": 483139
},
{
"price": 37.03,
"volume": 225748
},
{
"price": 37.15,
"volume": 201961
},
{
"price": 37.26,
"volume": 128944
},
{
"price": 37.37,
"volume": 73775
},
{
"price": 37.49,
"volume": 88954
},
{
"price": 37.6,
"volume": 95590
},
{
"price": 37.71,
"volume": 18140
},
{
"price": 37.83,
"volume": 77366
},
{
"price": 37.94,
"volume": 0
},
{
"price": 38.05,
"volume": 22267
},
{
"price": 38.17,
"volume": 78890
},
{
"price": 38.28,
"volume": 196606
},
{
"price": 38.39,
"volume": 104096
},
{
"price": 38.51,
"volume": 65030
},
{
"price": 38.62,
"volume": 241067
},
{
"price": 38.73,
"volume": 65276
},
{
"price": 38.85,
"volume": 344775
},
{
"price": 38.96,
"volume": 425677
},
{
"price": 39.07,
"volume": 198543
},
{
"price": 39.19,
"volume": 92493
},
{
"price": 39.3,
"volume": 80266
},
{
"price": 39.41,
"volume": 47850
},
{
"price": 39.53,
"volume": 44033
},
{
"price": 39.64,
"volume": 150625
},
{
"price": 39.75,
"volume": 294191
},
{
"price": 39.87,
"volume": 381651
},
{
"price": 39.98,
"volume": 358469
},
{
"price": 40.09,
"volume": 750871
},
{
"price": 40.21,
"volume": 612938
},
{
"price": 40.32,
"volume": 241989
},
{
"price": 40.43,
"volume": 63620
},
{
"price": 40.55,
"volume": 35317
},
{
"price": 40.66,
"volume": 92733
},
{
"price": 40.77,
"volume": 98136
},
{
"price": 40.89,
"volume": 199435
},
{
"price": 41.0,
"volume": 58684
},
{
"price": 41.11,
"volume": 41341
},
{
"price": 41.23,
"volume": 52959
},
{
"price": 41.34,
"volume": 138655
},
{
"price": 41.45,
"volume": 113670
},
{
"price": 41.57,
"volume": 120841
},
{
"price": 41.68,
"volume": 254591
},
{
"price": 41.79,
"volume": 251637
},
{
"price": 41.91,
"volume": 250727
},
{
"price": 42.02,
"volume": 79880
},
{
"price": 42.13,
"volume": 9509
},
{
"price": 42.25,
"volume": 56813
},
{
"price": 42.36,
"volume": 200594
},
{
"price": 42.47,
"volume": 136383
},
{
"price": 42.59,
"volume": 65948
}
],
"sessions": 20
}
}
Data:
{
"symbol": "IDYA",
"marketCap": 3792864859,
"enterpriseValueTTM": 3555287845,
"evToSalesTTM": 15.160929149564126,
"evToOperatingCashFlowTTM": -18.998693266178886,
"evToFreeCashFlowTTM": -18.681228469327607,
"evToEBITDATTM": -16.706906924532387,
"netDebtToEBITDATTM": 1.1450612344795774,
"currentRatioTTM": 10.450608996456088,
"incomeQualityTTM": 0.6829714979218378,
"grahamNumberTTM": null,
"grahamNetNetTTM": 7.926485343724537,
"taxBurdenTTM": 1,
"interestBurdenTTM": 0.8067185058514977,
"workingCapitalTTM": 781348000,
"investedCapitalTTM": 811807000,
"returnOnAssetsTTM": -0.13363375859644086,
"operatingReturnOnAssetsTTM": -0.18542619015771905,
"returnOnTangibleAssetsTTM": -0.13363375859644086,
"returnOnEquityTTM": -0.16468053275121497,
"returnOnInvestedCapitalTTM": -0.17664132902137417,
"returnOnCapitalEmployedTTM": -0.17681264068614908,
"earningsYieldTTM": -0.047659098467906065,
"freeCashFlowYieldTTM": -0.050096169271397706,
"capexToOperatingCashFlowTTM": -0.01699378589435485,
"capexToDepreciationTTM": 0.5635427760028399,
"capexToRevenueTTM": 0.013561016029761626,
"salesGeneralAndAdministrativeToRevenueTTM": 0.32919313022419455,
"researchAndDevelopementToRevenueTTM": 1.5974535188167105,
"stockBasedCompensationToRevenueTTM": 0.2978725221781341,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 10988500,
"averagePayablesTTM": 25622000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 24.034840065434572,
"daysOfPayablesOutstandingTTM": 41.97008872372022,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 24.034840065434572,
"cashConversionCycleTTM": -17.935248658285644,
"freeCashFlowToEquityTTM": -190008000,
"freeCashFlowToFirmTTM": -190008000,
"tangibleAssetValueTTM": 1198905000,
"netCurrentAssetValueTTM": 753231000,
"grossProfitMarginTTM": -0.133222567239148,
"ebitMarginTTM": -0.9266466490409051,
"ebitdaMarginTTM": -0.907464752036288,
"operatingProfitMarginTTM": -0.9266466490409051,
"pretaxProfitMarginTTM": -0.7475430001665763,
"continuousOperationsProfitMarginTTM": -0.7475430001665763,
"netProfitMarginTTM": -0.7475430001665763,
"bottomLineProfitMarginTTM": -0.7475430001665763,
"receivablesTurnoverTTM": 15.186287864046182,
"payablesTurnoverTTM": 8.696669725973516,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 7.686627926064546,
"assetTurnoverTTM": 0.17876397553941784,
"quickRatioTTM": 10.450608996456088,
"solvencyRatioTTM": -1.5391537447876238,
"cashRatioTTM": 3.2970354512137594,
"priceToEarningsRatioTTM": -20.807291666666668,
"priceToEarningsGrowthRatioTTM": -1.057191255684846,
"forwardPriceToEarningsGrowthRatioTTM": 2.081268286094541,
"priceToEarningsDilutedRatioTTM": -20.592783505154642,
"priceToEarningsDilutedGrowthRatioTTM": -1.0345093615176753,
"priceToBookRatioTTM": 3.067678429400161,
"priceToSalesRatioTTM": 16.224398915972955,
"priceToFreeCashFlowRatioTTM": -19.991631115531977,
"priceToOperatingCashFlowRatioTTM": -19.685253715350076,
"debtToAssetsRatioTTM": 0.022376897287086576,
"debtToEquityRatioTTM": 0.024444805885370402,
"debtToCapitalRatioTTM": 0.023861515764379438,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.0924126598854789,
"workingCapitalTurnoverRatioTTM": 0.33147815696179594,
"operatingCashFlowRatioTTM": -2.2597941386358964,
"operatingCashFlowSalesRatioTTM": -0.7979985221695917,
"freeCashFlowOperatingCashFlowRatioTTM": 1.016993785894355,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -6.375029856348313,
"capitalExpenditureCoverageRatioTTM": -58.84503937007874,
"dividendPaidAndCapexCoverageRatioTTM": -58.84503937007874,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 2.5431599753608056,
"netIncomePerShareTTM": -1.901121437884773,
"interestDebtPerShareTTM": 0.3183417094051482,
"cashPerShareTTM": 9.004365909849,
"bookValuePerShareTTM": 13.022877371084697,
"tangibleBookValuePerShareTTM": 13.022877371084697,
"shareholdersEquityPerShareTTM": 13.022877371084697,
"operatingCashFlowPerShareTTM": -2.029437901978778,
"capexPerShareTTM": 0.03448783319211607,
"freeCashFlowPerShareTTM": -2.063925735170894,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 0.8067185058514977,
"priceToFairValueTTM": 3.067678429400161,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -16.733758719206257,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 218710000
}
],
"dcf": {
"symbol": "IDYA",
"date": "2026-09-03",
"dcf": -112.01595793336894,
"Stock Price": 40.17
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "IDYA",
"reportedCurrency": "USD",
"cik": "0001676725",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:00:54",
"fiscalYear": "2025",
"period": "FY",
"revenue": 218710000,
"costOfRevenue": 314704000,
"grossProfit": -95994000,
"researchAndDevelopmentExpenses": 314704000,
"generalAndAdministrativeExpenses": 63319000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 63319000,
"otherExpenses": -314704000,
"operatingExpenses": 63319000,
"costAndExpenses": 378023000,
"netInterestIncome": 45615000,
"interestIncome": 45615000,
"interestExpense": 0,
"depreciationAndAmortization": 4593000,
"ebitda": -154720000,
"ebit": -159313000,
"nonOperatingIncomeExcludingInterest": 0,
"operatingIncome": -159313000,
"totalOtherIncomeExpensesNet": 45615000,
"incomeBeforeTax": -113698000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -113698000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -113698000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -113698000,
"eps": -1.28,
"epsDiluted": -1.28,
"weightedAverageShsOut": 88485238,
"weightedAverageShsOutDil": 88485238
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "IDYA",
"reportedCurrency": "USD",
"cik": "0001676725",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:00:54",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 112825000,
"shortTermInvestments": 526563000,
"cashAndShortTermInvestments": 639388000,
"netReceivables": 5973000,
"accountsReceivables": 0,
"otherReceivables": 5973000,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 21366000,
"totalCurrentAssets": 666727000,
"propertyPlantEquipmentNet": 31285000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 410297000,
"taxAssets": 0,
"otherNonCurrentAssets": 1015000,
"totalNonCurrentAssets": 442597000,
"otherAssets": 0,
"totalAssets": 1109324000,
"totalPayables": 17584000,
"accountPayables": 17584000,
"otherPayables": 0,
"accruedExpenses": 11198000,
"shortTermDebt": 339000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 29694000,
"totalCurrentLiabilities": 58815000,
"longTermDebt": 27575000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 27575000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 86390000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 9000,
"retainedEarnings": -736539000,
"additionalPaidInCapital": 1757197000,
"accumulatedOtherComprehensiveIncomeLoss": 2267000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 1022934000,
"totalEquity": 1022934000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 1109324000,
"totalInvestments": 936860000,
"totalDebt": 27914000,
"netDebt": -84911000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "IDYA",
"reportedCurrency": "USD",
"cik": "0001676725",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:00:54",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -113698000,
"depreciationAndAmortization": 4593000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 46115000,
"changeInWorkingCapital": 1868000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": 2697000,
"otherWorkingCapital": -829000,
"otherNonCashItems": -9976000,
"netCashProvidedByOperatingActivities": -71098000,
"investmentsInPropertyPlantAndEquipment": -2368000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -607889000,
"salesMaturitiesOfInvestments": 680233000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": 69976000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 29779000,
"netCommonStockIssuance": 29779000,
"commonStockIssuance": 29779000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 29779000,
"effectOfForexChangesOnCash": -210000,
"netChangeInCash": 28447000,
"cashAtEndOfPeriod": 112825000,
"cashAtBeginningOfPeriod": 84378000,
"operatingCashFlow": -71098000,
"capitalExpenditure": -2368000,
"freeCashFlow": -73466000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 39.89,
"rsi": 58.00942108706221,
"sma20": 38.937500000000014,
"sma50": 37.505799999999994,
"sma200": 33.70025000000002,
"adx": 27.652618257421874,
"atr": 1.42,
"atr_pct": 3.56,
"atr_expansion_pct": 19.2,
"di_plus": 37.2,
"di_minus": 12.0,
"high_52w": 42.48,
"low_52w": 23.39,
"structure": {
"ema8": 40.10901143447511,
"ema21": 39.090236202283606,
"ema50": 37.1711228093041,
"ema200": 33.209137324258535,
"ema10": 39.98820225437887,
"ema20": 39.16931202822436,
"ema10_slope_pct": 0.17,
"ema20_slope_pct": 1.46,
"trend_dir": "up",
"checks": {
"price_above_all": false,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 2.0,
"_no_bars": false,
"macd": {
"macd": 1.128,
"signal": 1.174,
"histogram": -0.046
},
"bollinger": {
"mid": 38.94,
"upper": 42.71,
"lower": 35.17,
"width_pct": 19.38
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 2.0,
"ret_3d": -0.52,
"ret_5d": -4.5,
"roc10_accel": -11.88,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.15,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -1.55,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": true,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 40346667.660000004,
"avg_vol": 1004398
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 4.0
}
}
}
}
Data:
{
"prior_day": {
"high": 40.66,
"low": 39.63,
"close": 39.95,
"date": "2026-09-03"
},
"woodie_pivots": {
"PP": 40.05,
"R1": 40.47,
"S1": 39.43,
"R2": 41.08,
"S2": 39.01
},
"swing": {
"high_20d": 42.68,
"low_20d": 35.66,
"high_60d": 42.68,
"low_60d": 26.81
},
"orb": {
"high": 40.66,
"low": 39.63,
"date": "2026-09-03"
},
"vwap": 40.03,
"volume_profile": {
"poc": 40.09,
"vah": 42.64,
"val": 37.77,
"sessions": 20
},
"premarket": {
"date": "2026-09-03",
"high": 40.3,
"low": 40.1,
"last": 40.26,
"volume": 1941,
"gap_pct": 0.22,
"path": "08:35 40.26",
"bars": 1,
"last_bar_et": "08:35"
},
"recent_daily": [
{
"d": "2026-07-31",
"o": 36.37,
"h": 36.63,
"l": 35.29,
"c": 35.5,
"v": 481985.594782
},
{
"d": "2026-08-03",
"o": 35.13,
"h": 35.9899,
"l": 34.56,
"c": 35.4,
"v": 395795.797862
},
{
"d": "2026-08-04",
"o": 36.295,
"h": 36.72,
"l": 35.21,
"c": 36.11,
"v": 1250312.426713
},
{
"d": "2026-08-05",
"o": 36.27,
"h": 36.97,
"l": 35.7812,
"c": 36.04,
"v": 1004923.117642
},
{
"d": "2026-08-06",
"o": 36.07,
"h": 36.9149,
"l": 36,
"c": 36.24,
"v": 497723.70329
},
{
"d": "2026-08-07",
"o": 36.5,
"h": 37.03,
"l": 36.27,
"c": 37.02,
"v": 602342.182288
},
{
"d": "2026-08-10",
"o": 36.98,
"h": 37.48,
"l": 36.175,
"c": 36.74,
"v": 717236.569218
},
{
"d": "2026-08-11",
"o": 36.48,
"h": 37.3525,
"l": 36.025,
"c": 36.84,
"v": 488601.700461
},
{
"d": "2026-08-12",
"o": 36.75,
"h": 37.2,
"l": 36.46,
"c": 36.96,
"v": 508832.306223
},
{
"d": "2026-08-13",
"o": 36.915,
"h": 37.63,
"l": 36.615,
"c": 36.68,
"v": 466192.522949
},
{
"d": "2026-08-14",
"o": 36.68,
"h": 36.68,
"l": 35.66,
"c": 36.3,
"v": 435255.115003
},
{
"d": "2026-08-17",
"o": 36.04,
"h": 36.82,
"l": 35.8,
"c": 36.54,
"v": 427842.182788
},
{
"d": "2026-08-18",
"o": 36.41,
"h": 37.975,
"l": 36.3883,
"c": 37.93,
"v": 629485.031887
},
{
"d": "2026-08-19",
"o": 39.01,
"h": 39.2995,
"l": 37.84,
"c": 38.87,
"v": 931923.979643
},
{
"d": "2026-08-20",
"o": 38.24,
"h": 39.28,
"l": 37.8894,
"c": 39.11,
"v": 1634020.419137
},
{
"d": "2026-08-21",
"o": 39.34,
"h": 40.56,
"l": 39.31,
"c": 39.67,
"v": 860570.44291
},
{
"d": "2026-08-24",
"o": 39.73,
"h": 40.46,
"l": 39.12,
"c": 40.04,
"v": 786770.760665
},
{
"d": "2026-08-25",
"o": 40.88,
"h": 42.68,
"l": 40.06,
"c": 42.48,
"v": 1022216.396835
},
{
"d": "2026-08-26",
"o": 42.26,
"h": 42.325,
"l": 41.09,
"c": 41.58,
"v": 724900.298638
},
{
"d": "2026-08-27",
"o": 41.63,
"h": 42.095,
"l": 40.965,
"c": 41.77,
"v": 534405.490044
},
{
"d": "2026-08-28",
"o": 41.14,
"h": 41.635,
"l": 40.04,
"c": 40.11,
"v": 714065.753958
},
{
"d": "2026-08-31",
"o": 39.74,
"h": 40.32,
"l": 39.43,
"c": 40.1,
"v": 977808.898274
},
{
"d": "2026-09-01",
"o": 39.85,
"h": 40.2,
"l": 38.9,
"c": 39.95,
"v": 587802.465883
},
{
"d": "2026-09-02",
"o": 40.2,
"h": 41.48,
"l": 39.58,
"c": 40.17,
"v": 765285.662822
},
{
"d": "2026-09-03",
"o": 40.41,
"h": 40.665,
"l": 39.63,
"c": 39.95,
"v": 102827.64842
}
]
}
Data:
{
"estimates": [
{
"symbol": "IDYA",
"date": "2030-12-31",
"revenueLow": 332150827,
"revenueHigh": 2005917301,
"revenueAvg": 1043372875,
"ebitdaLow": 76827285,
"ebitdaHigh": 407348773,
"ebitdaAvg": 217273520,
"ebitLow": 18043148,
"ebitHigh": 348564636,
"ebitAvg": 158489383,
"netIncomeLow": 14254087,
"netIncomeHigh": 275366063,
"netIncomeAvg": 125206613,
"sgaExpenseLow": 496847420,
"sgaExpenseHigh": 3000549014,
"sgaExpenseAvg": 1560728077,
"epsAvg": 1.415,
"epsHigh": 3.112,
"epsLow": 0.16109,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
},
{
"symbol": "IDYA",
"date": "2029-12-31",
"revenueLow": 180568134,
"revenueHigh": 1090482742,
"revenueAvg": 567211875,
"ebitdaLow": -264158827,
"ebitdaHigh": 15175798,
"ebitdaAvg": -103520070,
"ebitLow": -294583287,
"ebitHigh": -15248661,
"ebitAvg": -133944530,
"netIncomeLow": -294583287,
"netIncomeHigh": -15248661,
"netIncomeAvg": -133944530,
"sgaExpenseLow": 270102629,
"sgaExpenseHigh": 1631197315,
"sgaExpenseAvg": 848463210,
"epsAvg": -1.51375,
"epsHigh": -0.17233,
"epsLow": -3.32918,
"numAnalystsRevenue": 10,
"numAnalystsEps": 4
},
{
"symbol": "IDYA",
"date": "2028-12-31",
"revenueLow": 117511789,
"revenueHigh": 452655998,
"revenueAvg": 254787419,
"ebitdaLow": -378652114,
"ebitdaHigh": -14933539,
"ebitdaAvg": -323582200,
"ebitLow": -393276184,
"ebitHigh": -29557609,
"ebitAvg": -338206270,
"netIncomeLow": -393276184,
"netIncomeHigh": -29557609,
"netIncomeAvg": -338206270,
"sgaExpenseLow": 175779870,
"sgaExpenseHigh": 677104937,
"sgaExpenseAvg": 381123458,
"epsAvg": -3.35523,
"epsHigh": -0.33404,
"epsLow": -4.44454,
"numAnalystsRevenue": 12,
"numAnalystsEps": 11
},
{
"symbol": "IDYA",
"date": "2027-12-31",
"revenueLow": 30829835,
"revenueHigh": 219954328,
"revenueAvg": 115516084,
"ebitdaLow": -454133083,
"ebitdaHigh": -155042357,
"ebitdaAvg": -400741292,
"ebitLow": -461899141,
"ebitHigh": -162808415,
"ebitAvg": -408507350,
"netIncomeLow": -461899141,
"netIncomeHigh": -162808415,
"netIncomeAvg": -408507350,
"sgaExpenseLow": 46116772,
"sgaExpenseHigh": 329018420,
"sgaExpenseAvg": 172794597,
"epsAvg": -4.13471,
"epsHigh": -1.83995,
"epsLow": -5.22007,
"numAnalystsRevenue": 10,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "IDYA",
"targetHigh": 63,
"targetLow": 48,
"targetConsensus": 57,
"targetMedian": 60
},
"ratings": {
"symbol": "IDYA",
"rating": "C",
"overallScore": 2,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "IDYA",
"date": "2026-09-01",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-08-05",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-08-05",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-07-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-06-12",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-06-02",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-05-07",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-04-14",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-04-14",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-04-14",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-04-14",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-04-14",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-03-31",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-02-19",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-02-18",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-02-18",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-02-18",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-01-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2026-01-06",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-11-11",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-10-23",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-10-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-10-21",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-10-21",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-12",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-09",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-09",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-09",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-08",
"gradingCompany": "JMP Securities",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "IDYA",
"date": "2025-09-03",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-london-investor-rd-day-and-participation-in-upcoming-september-2026-investor-conferences-302865528.html",
"source": "PRNewsWire",
"date": "2026-09-01 06:00:00",
"summary": "SOUTH SAN FRANCISCO, Calif., Sept. 1, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced its upcoming Investor R&D Day in London and participation",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-london-investor-rd-day-and-participation-20260901.jpg"
},
{
"title": "IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-successful-fda-type-c-meeting-for-ide849-dll3-top1-adc-on-phase-3-registrational-trial-design-for-potential-accelerated-and-full-approval-in-extensive-stage-small-cell-lung-cancer-302864315.html",
"source": "PRNewsWire",
"date": "2026-08-31 06:00:00",
"summary": "Based on FDA Type C meeting, targeting to initiate a randomized Phase 3 registrational trial for IDE849 monotherapy by year-end 2026 in ES-SCLC, with ORR by BICR as the primary endpoint for potential accelerated approval and median OS as the primary endpoint for potential full ap",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-successful-fda-type-c-meeting-for-20260831.jpg"
},
{
"title": "IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.gurufocus.com/news/9057936/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4",
"source": "GuruFocus",
"date": "2026-08-28 07:00:00",
"summary": "IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISC",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-20260828.png"
},
{
"title": "Ideaya Biosciences: Darovasertib De-Risks A Self-Reinforcing Oncology Platform",
"url": "https://seekingalpha.com/article/4939938-ideaya-biosciences-darovasertib-de-risks-a-self-reinforcing-oncology-platform",
"source": "Seeking Alpha",
"date": "2026-08-25 09:13:35",
"summary": "IDEAYA Biosciences is transitioning into a commercial oncology platform, leveraging darovasertib's registrational success and a robust internal pipeline. Darovasertib's phase 2 trial showed a median PFS of 6.9 vs. 3.1 months, supporting NDA submission and U.S. commercialization p",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-darovasertib-derisks-a-selfreinforcing-oncology-platform-20260825.jpg"
},
{
"title": "IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-clinical-collaboration-with-genentech-in-mtap-deleted-kras-g12d-mutant-pancreatic-cancer-302854505.html",
"source": "PRNewsWire",
"date": "2026-08-19 06:00:00",
"summary": "IDEAYA entered into a clinical collaboration to evaluate IDE892, IDEAYA's potential best-in-class Phase 1 MTA-cooperative PRMT5 inhibitor, in combination with RG6620, Genentech's Phase 1 KRAS G12D inhibitor, in MTAP-deleted, KRAS G12D-mutant pancreatic ductal adenocarcinoma Genen",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-clinical-collaboration-with-genentech-in-mtapdeleted-20260819.jpg"
},
{
"title": "IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-reports-second-quarter-2026-financial-results-and-provides-business-update-302841723.html",
"source": "PRNewsWire",
"date": "2026-08-04 06:00:00",
"summary": "Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing is underway under the real-time oncology review program (RTOR) with completion expected in H2 2026 Updated data from Phas",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-reports-second-quarter-2026-financial-results-and-20260804.jpg"
},
{
"title": "IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-ide892-a-potential-best-in-class-mta-cooperative-prmt5-inhibitor-initiates-part-2-monotherapy-expansion-in-the-phase-12-study-in-mtap-deleted-pancreatic-and-lung-cancers-302834359.html",
"source": "PRNewsWire",
"date": "2026-07-27 06:00:00",
"summary": "IDE892 is a potential best-in-class PRMT5 inhibitor with 1,400-fold selective MTA-PRMT5 cooperative binding vs SAM-PRMT5 cooperative binding, and CYP3A4 IC50 greater than 45 micromolar with no time-dependent inhibition of the 7 major cytochrome P450s IDE892 Phase 1/2 escalation h",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-ide892-a-potential-bestinclass-mtacooperative-prmt5-20260727.jpg"
},
{
"title": "IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-esmo-2026-presentations-for-darovasertib-and-ide849-clinical-programs-302828546.html",
"source": "PRNewsWire",
"date": "2026-07-17 09:00:00",
"summary": "SOUTH SAN FRANCISCO, Calif., July 17, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced three abstract presentations at the 2026 European Society of Medical Oncology (ESMO) meeting, taking place on October",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-esmo-2026-presentations-for-darovasertib-and-20260717.jpg"
},
{
"title": "IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors",
"url": "https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-yujiro-s-hata-elected-chairman-of-its-board-of-directors-302802421.html",
"source": "PRNewsWire",
"date": "2026-06-17 06:00:00",
"summary": "SOUTH SAN FRANCISCO, Calif., June 17, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that its Board of Directors has elected Yujiro S.",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-announces-yujiro-s-hata-elected-chairman-of-20260617.jpg"
},
{
"title": "Ideaya Biosciences: 'Strong Buy' On Darovasertib NDA Filing Submission Completion In H2 2026",
"url": "https://seekingalpha.com/article/4914071-ideaya-biosciences-strong-buy-darovasertib-nda-filing-submission-completion-h2-2026",
"source": "Seeking Alpha",
"date": "2026-06-11 03:22:42",
"summary": "IDEAYA Biosciences maintains a \"Strong Buy\" rating, driven by positive darovasertib data in uveal melanoma and robust clinical progress. The company's darovasertib + crizotinib met the mPFS primary endpoint in 1st-line HLA*A2-negative mUM, supporting an RTOR NDA Accelerated Appro",
"image": "https://images.financialmodelingprep.com/news/ideaya-biosciences-strong-buy-on-darovasertib-nda-filing-submission-20260611.jpg"
},
{
"title": "IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares",
"url": "https://www.prnewswire.com/news-releases/ideaya-announces-closing-of-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302797230.html",
"source": "PRNewsWire",
"date": "2026-06-10 16:05:00",
"summary": "SOUTH SAN FRANCISCO, Calif., June 10, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced the closing of its underwritten public offering of 7,222,225 shares of its common stock at a public offering price of $27.00 per share, before underwriting discounts",
"image": "https://images.financialmodelingprep.com/news/ideaya-announces-closing-of-public-offering-including-full-exercise-20260610.jpg"
},
{
"title": "IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars",
"url": "https://www.benzinga.com/news/health-care/26/04/51775855/ideaya-eye-cancer-trial-data-beats-standard-therapy-stock-soars?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-13T11:48:12Z",
"summary": "IDEAYA Biosciences announced positive Phase 2/3 trial results for darovasertib combined with crizotinib in treating metastatic uveal melanoma. The combination showed a median progression-free survival of 6.9 months versus 3.1 months for standard therapy, with a 37.1% overall resp",
"image": "https://cdn.benzinga.com/files/images/story/2026/04/13/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies",
"url": "https://www.globenewswire.com/news-release/2025/12/17/3207093/0/en/Antibody-Optimization-Service-Market-Set-to-Reach-USD-6-07-Billion-by-2034-Growing-at-an-8-45-CAGR-Amid-Advances-in-Gene-Editing-Technologies.html",
"source": "GlobeNewswire Inc.",
"date": "2025-12-17T15:00:00Z",
"summary": "The global antibody optimization service market is projected to grow from USD 2.77 billion in 2024 to USD 6.07 billion by 2034, driven by advances in gene-editing technologies, AI/computational tools, and increasing biologics R&D.",
"image": "https://ml.globenewswire.com/Resource/Download/01eb1f79-0c67-420b-b423-376619f975cd"
},
{
"title": "Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2025/10/14/3166557/0/en/Melanoma-Clinical-Trial-Pipeline-Accelerates-as-150-Pharma-Companies-Rigorously-Develop-Drugs-for-Market-Entry-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2025-10-14T17:00:00Z",
"summary": "Over 150 pharmaceutical companies are actively developing 170+ pipeline melanoma drugs, with promising therapies in various clinical trial stages targeting improved treatment outcomes through immunotherapies and targeted treatments.",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
}
]
Data:
[
{
"symbol": "IDYA",
"date": "2026-11-09",
"epsActual": null,
"epsEstimated": -1.17781,
"revenueActual": null,
"revenueEstimated": 9921429,
"lastUpdated": "2026-09-03"
},
{
"symbol": "IDYA",
"date": "2026-08-04",
"epsActual": -1.22,
"epsEstimated": -1.06,
"revenueActual": 8857000,
"revenueEstimated": 8019538,
"lastUpdated": "2026-09-03"
},
{
"symbol": "IDYA",
"date": "2026-05-05",
"epsActual": -1.11,
"epsEstimated": -1.07,
"revenueActual": 6560000,
"revenueEstimated": 5038375,
"lastUpdated": "2026-08-05"
},
{
"symbol": "IDYA",
"date": "2026-02-17",
"epsActual": -0.94,
"epsEstimated": -0.95172,
"revenueActual": 10876000,
"revenueEstimated": 6305875,
"lastUpdated": "2026-05-17"
},
{
"symbol": "IDYA",
"date": "2025-11-04",
"epsActual": 1.33,
"epsEstimated": -0.94597,
"revenueActual": 207834000,
"revenueEstimated": 5946470,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "IDYA",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "IDYA",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260420",
"quantity_fails": 162,
"price": 33.91
},
{
"file_period": "202606a",
"settlement_date": "20260612",
"quantity_fails": 24425,
"price": 28.84
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 100732,
"price": 36.55
},
{
"file_period": "202607a",
"settlement_date": "20260702",
"quantity_fails": 3,
"price": 36.17
},
{
"file_period": "202607b",
"settlement_date": "20260730",
"quantity_fails": 6,
"price": 35.59
},
{
"file_period": "202608a",
"settlement_date": "20260814",
"quantity_fails": 3,
"price": 36.68
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "IDYA",
"filingDate": "2026-07-09",
"transactionDate": "2026-07-07",
"reportingCik": "0001983118",
"companyCik": "0001676725",
"transactionType": "M-Exempt",
"securitiesOwned": 36016,
"reportingName": "Ruiz Briseno Andres",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9550,
"price": 12.86,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/0001610717-26-000336-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-07-09",
"transactionDate": "2026-07-07",
"reportingCik": "0001983118",
"companyCik": "0001676725",
"transactionType": "S-Sale",
"securitiesOwned": 26466,
"reportingName": "Ruiz Briseno Andres",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9550,
"price": 40.0137,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/0001610717-26-000336-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-07-09",
"transactionDate": "2026-07-07",
"reportingCik": "0001983118",
"companyCik": "0001676725",
"transactionType": "M-Exempt",
"securitiesOwned": 19200,
"reportingName": "Ruiz Briseno Andres",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9550,
"price": 12.86,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/0001610717-26-000336-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001181186",
"companyCik": "0001676725",
"transactionType": "A-Award",
"securitiesOwned": 20000,
"reportingName": "YARNO WENDY L",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 30.57,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000265/0001610717-26-000265-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001478831",
"companyCik": "0001676725",
"transactionType": "A-Award",
"securitiesOwned": 20000,
"reportingName": "Stein Jeffrey",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 30.57,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000264/0001610717-26-000264-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001182473",
"companyCik": "0001676725",
"transactionType": "A-Award",
"securitiesOwned": 20000,
"reportingName": "ROSEN TERRY J",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 30.57,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000263/0001610717-26-000263-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001662426",
"companyCik": "0001676725",
"transactionType": "A-Award",
"securitiesOwned": 20000,
"reportingName": "Morrison Scott W",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 30.57,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000261/0001610717-26-000261-index.htm"
},
{
"symbol": "IDYA",
"filingDate": "2026-06-18",
"transactionDate": "2026-06-16",
"reportingCik": "0001645330",
"companyCik": "0001676725",
"transactionType": "A-Award",
"securitiesOwned": 20000,
"reportingName": "MACKEY CATHERINE J",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 30.57,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1676725/000161071726000260/0001610717-26-000260-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "IDYA",
"executed_at": "2026-09-03T14:55:26.898000Z",
"size": 300.0,
"price": 39.89,
"premium": 11967.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:17:32.048000Z",
"size": 240.0,
"price": 39.88,
"premium": 9571.2,
"volume": 240.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T14:55:26.898000Z",
"size": 240.0,
"price": 39.865,
"premium": 9567.6,
"volume": 240.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:26:04.201000Z",
"size": 200.0,
"price": 39.975,
"premium": 7995.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:24:45.544000Z",
"size": 200.0,
"price": 39.895,
"premium": 7979.000000000001,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:24:45.534000Z",
"size": 200.0,
"price": 39.895,
"premium": 7979.000000000001,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:18:59.477000Z",
"size": 200.0,
"price": 39.85,
"premium": 7970.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "IDYA",
"executed_at": "2026-09-03T15:18:07.874000Z",
"size": 200.0,
"price": 39.87,
"premium": 7973.999999999999,
"volume": 200.0,
"trade_code": " "
}
],
"ats": {
"symbol": "IDYA",
"date": "20260902",
"ats_volume": 0,
"total_volume": 305509,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260902",
"ats_ratio": 0.0
},
{
"date": "20260901",
"ats_ratio": 0.0
},
{
"date": "20260831",
"ats_ratio": 0.0
},
{
"date": "20260828",
"ats_ratio": 0.0
},
{
"date": "20260827",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "IDYA",
"days": [
{
"date": "2026-09-03",
"close": 39.95,
"vwap": 40.03,
"volume": 102827,
"vwap_discount_pct": 0.19
},
{
"date": "2026-09-02",
"close": 40.17,
"vwap": 40.11,
"volume": 765285,
"vwap_discount_pct": -0.15
},
{
"date": "2026-09-01",
"close": 39.95,
"vwap": 39.65,
"volume": 587802,
"vwap_discount_pct": -0.75
},
{
"date": "2026-08-31",
"close": 40.1,
"vwap": 40.02,
"volume": 977808,
"vwap_discount_pct": -0.19
},
{
"date": "2026-08-28",
"close": 40.11,
"vwap": 40.56,
"volume": 714065,
"vwap_discount_pct": 1.12
}
],
"avg_vwap_discount_pct": 0.04,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "IDYA",
"net_call_premium": "-14.00",
"net_put_premium": "-55.00",
"call_premium": "14.00",
"put_premium": "305.00",
"bullish_premium": "180.00",
"bearish_premium": "139.00",
"put_call_ratio": "2.0000000000000000",
"iv_rank": "3.5577",
"implied_move_perc": "0.065000",
"gex_ratio": "0.17405913587572765358",
"gex_net_change": "509.3583",
"gex_call": "2922.5102",
"gex_put": "-508.6896",
"gex_net": 2413.8206,
"gex_call_delta": "93749.8228",
"gex_put_delta": "-2361.1948",
"gex_date": "2026-09-03"
},
"hot_chains": [
{
"underlying_symbol": "IDYA",
"expires": "2026-09-18",
"open_interest": 8,
"option_type": "put",
"delta": -0.526813751495956,
"ask_volume": 1,
"last_price": "1.25",
"implied_volatility": "0.487153205518717",
"gamma": 0.315364414568385,
"avg_price": "1.25",
"bid_volume": 0,
"nbbo_ask": "1.60",
"strike": "40",
"option_symbol": "IDYA260918P00040000",
"total_premium": "125.00",
"iv": 0.1550785632854179,
"volume": 1,
"nbbo_bid": "0.85"
},
{
"underlying_symbol": "IDYA",
"expires": "2027-04-16",
"open_interest": 0,
"option_type": "put",
"delta": -0.196881957136932,
"ask_volume": 0,
"last_price": "1.80",
"implied_volatility": "0.535452359760224",
"gamma": 0.01523221906161607,
"avg_price": "1.80",
"bid_volume": 1,
"nbbo_ask": "2.25",
"strike": "30",
"option_symbol": "IDYA270416P00030000",
"total_premium": "180.00",
"iv": 0.580993209747516,
"volume": 1,
"nbbo_bid": "1.50"
},
{
"underlying_symbol": "IDYA",
"expires": "2026-09-18",
"open_interest": 13,
"option_type": "call",
"delta": 0.112858561802354,
"ask_volume": 0,
"last_price": "0.14",
"implied_volatility": "0.4185512931585708",
"gamma": 0.0504265395777029,
"avg_price": "0.14",
"bid_volume": 1,
"nbbo_ask": "0.30",
"strike": "45",
"option_symbol": "IDYA260918C00045000",
"total_premium": "14.00",
"iv": 0.466369283680168,
"volume": 1,
"nbbo_bid": "0.10"
},
{
"underlying_symbol": "IDYA",
"expires": "2026-10-16",
"open_interest": 209,
"option_type": "call",
"delta": 0.826120141306283,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0424295927138525,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "35",
"option_symbol": "IDYA261016C00035000",
"total_premium": "0",
"iv": 0.440892776905395,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IDYA",
"expires": "2027-01-15",
"open_interest": 140,
"option_type": "call",
"delta": 0.81919689496001,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01653954640651995,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "30",
"option_symbol": "IDYA270115C00030000",
"total_premium": "0",
"iv": 0.657996331279946,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IDYA",
"expires": "2027-12-17",
"open_interest": 135,
"option_type": "call",
"delta": 0.589568432276513,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01503950968742764,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "42.5",
"option_symbol": "IDYA271217C00042500",
"total_premium": "0",
"iv": 0.570971292615312,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IDYA",
"expires": "2026-09-18",
"open_interest": 126,
"option_type": "call",
"delta": 0.0392203448811163,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01711732899827921,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "50",
"option_symbol": "IDYA260918C00050000",
"total_premium": "0",
"iv": 0.609096878036268,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IDYA",
"expires": "2026-10-16",
"open_interest": 117,
"option_type": "call",
"delta": 0.999983964610309,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 1.540620442017932e-05,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "25",
"option_symbol": "IDYA261016C00025000",
"total_premium": "0",
"iv": 0.331735663337206,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "IDYA",
"spot": 39.92,
"date": "2026-09-03",
"flip_point": 27.72,
"net_gex": 2413.82,
"call_walls": [
{
"strike": 35.0,
"gex": 891.59
},
{
"strike": 40.0,
"gex": 527.21
},
{
"strike": 50.0,
"gex": 388.28
}
],
"put_walls": [
{
"strike": 40.0,
"gex": -203.5
},
{
"strike": 35.0,
"gex": -138.54
},
{
"strike": 37.5,
"gex": -86.28
}
],
"by_strike": [
{
"strike": 15.0,
"call_gex": 0.93,
"put_gex": -0.82,
"net_gex": 0.11
},
{
"strike": 17.5,
"call_gex": 0.9,
"put_gex": -0.37,
"net_gex": 0.52
},
{
"strike": 20.0,
"call_gex": 0.54,
"put_gex": -3.01,
"net_gex": -2.47
},
{
"strike": 22.5,
"call_gex": 0.0,
"put_gex": -8.89,
"net_gex": -8.89
},
{
"strike": 25.0,
"call_gex": 1.88,
"put_gex": -11.41,
"net_gex": -9.53
},
{
"strike": 27.5,
"call_gex": 0.93,
"put_gex": -6.94,
"net_gex": -6.01
},
{
"strike": 30.0,
"call_gex": 317.69,
"put_gex": -18.3,
"net_gex": 299.39
},
{
"strike": 32.5,
"call_gex": 6.8,
"put_gex": -30.63,
"net_gex": -23.82
},
{
"strike": 35.0,
"call_gex": 891.59,
"put_gex": -138.54,
"net_gex": 753.05
},
{
"strike": 37.5,
"call_gex": 204.48,
"put_gex": -86.28,
"net_gex": 118.19
},
{
"strike": 40.0,
"call_gex": 527.21,
"put_gex": -203.5,
"net_gex": 323.72
},
{
"strike": 42.5,
"call_gex": 316.57,
"put_gex": 0.0,
"net_gex": 316.57
},
{
"strike": 45.0,
"call_gex": 249.47,
"put_gex": 0.0,
"net_gex": 249.47
},
{
"strike": 47.5,
"call_gex": 11.5,
"put_gex": 0.0,
"net_gex": 11.5
},
{
"strike": 50.0,
"call_gex": 388.28,
"put_gex": 0.0,
"net_gex": 388.28
},
{
"strike": 55.0,
"call_gex": 3.73,
"put_gex": 0.0,
"net_gex": 3.73
},
{
"strike": 60.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
}
]
},
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 0,
"top": [
{
"strike": "35",
"oi_change": 0,
"type": "call"
},
{
"strike": "30",
"oi_change": 0,
"type": "call"
},
{
"strike": "42.5",
"oi_change": 0,
"type": "call"
},
{
"strike": "50",
"oi_change": 0,
"type": "call"
},
{
"strike": "25",
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -2.0,
"D": -7.5,
"P": -9.1,
"O": -24.1,
"C": 26.7,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": -11.3,
"T": 38.9,
"RS": -74.4,
"V": -0.0,
"F": 12.9,
"OI": null,
"S": -100.0,
"IV": -52.8,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 66.7,
"StrikeBreadth": null
},
"drivers": [
"- skew -100",
"- relative strength -74",
"- IV behaviour -53",
"+ trend +39"
]
}
}
Data:
{
"vix": 14.92,
"sp500": 7686.14,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.41,
"hy_spread": 2.6,
"treasury": {
"date": "2026-09-01",
"month1": 3.85,
"month2": 3.89,
"month3": 3.92,
"month6": 4,
"year1": 4.18,
"year2": 4.39,
"year3": 4.46,
"year5": 4.55,
"year7": 4.66,
"year10": 4.79,
"year20": 5.27,
"year30": 5.27
},
"events": [
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.1%",
"actual": null,
"minutes_until": 1280
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "55K",
"previous": "-23K",
"actual": null,
"minutes_until": 1280
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 1280
}
]
}
Data:
{
"days": 106,
"patterns": [
{
"name": "VWAP Touch",
"count": 106,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 106,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 106,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 102,
"pct": 96
},
{
"name": "Woodie Pivot Touch",
"count": 101,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 91,
"pct": 86
},
{
"name": "Open Retracement",
"count": 77,
"pct": 73
},
{
"name": "Gap Fill",
"count": 75,
"pct": 71
},
{
"name": "Darvas Box",
"count": 43,
"pct": 41
},
{
"name": "High Vol Open",
"count": 40,
"pct": 38
},
{
"name": "Power Hour",
"count": 19,
"pct": 18
}
]
}